BioSpace News Archive

Drug Development

Oligomerix, Inc., Awarded $2.18 Million SBIR Grant for Tau Oligomer Inhibitor for Alzheimer’s Disease and Related Disorders

Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer’s disease (AD) and related neurodegenerative disorders, announced today the receipt of a $2.18 million Direct-to-Phase-II Small Business Innovation Research (SBIR) grant

October 10, 2019
·
3 min read
Bio NC

Aruna Bio Awarded $4.5 Million SBIR Phase II Grant to Support Development of Neural Exosome AB126

Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the company has been awarded a Small Business Innovation Research (SBIR) Phase II grant by the National Institutes of Health in the amount of $4.5 million

October 10, 2019
·
2 min read
Business

Thrive Global Launches Groundbreaking Program to Improve Mental Health

Thrive Global announced today a groundbreaking program in partnership with Stanford Medicine to help companies unlock better mental health

October 10, 2019
·
5 min read
Business

Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors

Innovent Biologics, Inc. and Hutchison China MediTech Limited announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent’s Tyvyt®

October 10, 2019
·
9 min read
Drug Development

Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis

Galderma announced that it has enrolled the first patients in a new Phase 3 clinical study with nemolizumab, an investigational therapy in adult patients with moderate-to-severe atopic dermatitis.

October 10, 2019
·
3 min read
BIA Separations introduces CORNERSTONE Exosome Process Development Solution to Enable Industrial Scale Manufacture of Therapeutic Exosomes

BIA Separations announced the introduction of its CORNERSTONE Exosome Process Development Solution, designed to help drug-developers overcome critical development bottlenecks in the preparation of exosomes for clinical use.

October 10, 2019
·
3 min read
Business

Digirad Corporation to Present at the MicroCap Rodeo Conference on October 15th in Austin, Texas

Digirad Corporation announced that its management will be presenting the holding company (“HoldCo”) strategy at the MicroCap Rodeo Conference at the Hilton Austin (TX) on October 15th.

October 10, 2019
·
3 min read
Now You Can Get Your Whole Genome Sequenced in Only 2 Weeks With Dante Labs

Dante Labs introduced Whole Genome and WholeGenomeZ™ Sequencing and reports with a best-in-class two week turnaround time thanks to its brand new European sequencing centre

October 10, 2019
·
2 min read
Deals

CytoSorbents to Present at The MicroCap Rodeo Investor Conference

CytoSorbents Corporation announced that company management will present an overview of the company at The MicroCap Rodeo Investor Conference on Tuesday, October 15, 2019 in Austin, TX and meet with investors in 1x1 meetings throughout the day.

October 10, 2019
·
4 min read
Policy

Lawsuit Settlement News Announces Assistance for Plaintiffs in Roundup Weed Killer Lawsuits

Premier mass tort servicing firm available to help plaintiffs find a lawyer or seek lawsuit funding from their Bayer Monsanto case

October 10, 2019
·
2 min read